Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Science Advances
|
June 18, 2025
The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5
Man Zhao, Dalin Zhang, Haowen Jiang, et al.
Nature Communications
|
March 26, 2021
Author Correction: Pharmacophore hybridisation and nanoscale assembly to discover self-delivering lysosomotropic new-chemical entities for cancer therapy
Zhao Ma, Jin Li, Kai Lin, et al.
Nature Communications
|
September 16, 2020
Pharmacophore hybridisation and nanoscale assembly to discover self-delivering lysosomotropic new-chemical entities for cancer therapy
Zhao Ma, Jin Li, Kai Lin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 23, 2023
Programmed-response cross-linked nanocarrier for multidrug-resistant ovarian cancer treatment
Haijing Qu, Jinfan Yang, Shuaijun Li, et al.
Biomaterials
|
August 1, 2020
A nephrotoxicity-free, iron-based contrast agent for magnetic resonance imaging of tumors
Xiangdong Xue, Ruonan Bo, Haijing Qu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
September 2, 2024
Establishing and Characterizing the Molecular Profiles, Cellular Features, and Clinical Utility of a Patient-Derived Xenograft Model Using Benign Prostatic Tissues
Alexandra Lapat Polasko, Dalin Zhang, Avanti Ramraj, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 10, 2026
Erratum to "Establishing and characterizing the molecular profiles, cellular features, and clinical utility of a patient-derived xenograft model using benign prostatic tissues" (Lab Invest 2024 Oct;104(10):102129)
Alexandra Lapat Polasko, Dalin Zhang, Avanti Ramraj, et al.
The Journal of Clinical Investigation
|
January 2, 2026
Identification of serum protein biomarkers for clear cell renal cell carcinoma using patient-derived xenografts
Dalin Zhang, Chun-Lung Chiu, Fernando Jose Garcia Marques, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2025
Targeting AXL Inhibits the Growth and Metastasis of Prostate Cancer in Bone
Chun-Lung Chiu, Dalin Zhang, Hongjuan Zhao, et al.
Nano Letters
|
August 4, 2022
Programmable Bispecific Nano-immunoengager That Captures T Cells and Reprograms Tumor Microenvironment
Lu Zhang, Ruonan Bo, Yi Wu, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Science Advances
|
June 18, 2025
The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5
Man Zhao, Dalin Zhang, Haowen Jiang, et al.
Nature Communications
|
March 26, 2021
Author Correction: Pharmacophore hybridisation and nanoscale assembly to discover self-delivering lysosomotropic new-chemical entities for cancer therapy
Zhao Ma, Jin Li, Kai Lin, et al.
Nature Communications
|
September 16, 2020
Pharmacophore hybridisation and nanoscale assembly to discover self-delivering lysosomotropic new-chemical entities for cancer therapy
Zhao Ma, Jin Li, Kai Lin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 23, 2023
Programmed-response cross-linked nanocarrier for multidrug-resistant ovarian cancer treatment
Haijing Qu, Jinfan Yang, Shuaijun Li, et al.
Biomaterials
|
August 1, 2020
A nephrotoxicity-free, iron-based contrast agent for magnetic resonance imaging of tumors
Xiangdong Xue, Ruonan Bo, Haijing Qu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
September 2, 2024
Establishing and Characterizing the Molecular Profiles, Cellular Features, and Clinical Utility of a Patient-Derived Xenograft Model Using Benign Prostatic Tissues
Alexandra Lapat Polasko, Dalin Zhang, Avanti Ramraj, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 10, 2026
Erratum to "Establishing and characterizing the molecular profiles, cellular features, and clinical utility of a patient-derived xenograft model using benign prostatic tissues" (Lab Invest 2024 Oct;104(10):102129)
Alexandra Lapat Polasko, Dalin Zhang, Avanti Ramraj, et al.
The Journal of Clinical Investigation
|
January 2, 2026
Identification of serum protein biomarkers for clear cell renal cell carcinoma using patient-derived xenografts
Dalin Zhang, Chun-Lung Chiu, Fernando Jose Garcia Marques, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2025
Targeting AXL Inhibits the Growth and Metastasis of Prostate Cancer in Bone
Chun-Lung Chiu, Dalin Zhang, Hongjuan Zhao, et al.
Nano Letters
|
August 4, 2022
Programmable Bispecific Nano-immunoengager That Captures T Cells and Reprograms Tumor Microenvironment
Lu Zhang, Ruonan Bo, Yi Wu, et al.
Page
of 9